NSG
INSP icon

Nalls Sherbakoff Group’s Inspire Medical Systems INSP Stock Holding History

Nalls Sherbakoff Group’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$611 Sell
3
-3
-50% -$486 ﹤0.01% 412
2023
Q3 		$1.19K Hold
6
– – ﹤0.01% 387
2023
Q2 		$1.75K Hold
6
– – ﹤0.01% 373
2023
Q1 		$1.43K Buy
+6
New +$1.52K ﹤0.01% 410

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Nalls Sherbakoff Group's INSP Position: Q4 2023 in Review

Nalls Sherbakoff Group reduced its Inspire Medical Systems (INSP) stake by 50% in Q4 2023, selling an estimated $486 and leaving 3 shares worth $611. The position accounts for ﹤0.01% of the portfolio, ranked #412.

Nalls Sherbakoff Group first reported a position in INSP in Q1 2023 and has held it in 4 quarters since. The position peaked at $1.75K in Q2 2023. 343 funds tracked by Wall St. Rank hold INSP as of Q4 2023.

  • Nalls Sherbakoff Group held 3 shares of Inspire Medical Systems worth $611 as of Q4 2023.
  • Nalls Sherbakoff Group sold 3 Inspire Medical Systems shares in Q4 2023, an estimated $486.
  • Inspire Medical Systems made up ﹤0.01% of Nalls Sherbakoff Group's portfolio in Q4 2023, its #412 holding.
  • Nalls Sherbakoff Group first reported a position in Inspire Medical Systems in Q1 2023 and has held it in 4 quarters since.
  • Nalls Sherbakoff Group's Inspire Medical Systems position peaked at $1.75K in Q2 2023.
  • 343 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2023.

Based on Nalls Sherbakoff Group's 13F filing for Q4 2023, filed 9 Apr 2024.